Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 2

Vascular risk factors, cognitve decline, and dementia

Authors E Duron, Olivier Hanon

Published Date May 2008 Volume 2008:4(2) Pages 363—381

DOI http://dx.doi.org/10.2147/VHRM.S1839

Published 6 May 2008

E Duron, Olivier Hanon

Broca Hospital, Paris, France

Abstract: Dementia is one of the most important neurological disorders in the elderly. Aging is associated with a large increase in the prevalence and incidence of degenerative (Alzheimer’s disease) and vascular dementia, leading to a devastating loss of autonomy. In view of the increasing longevity of populations worldwide, prevention of dementia has turned into a major public health challenge. In the past decade, several vascular risk factors have been found to be associated with vascular dementia but also Alzheimer’s disease. Some longitudinal studies, have found significant associations between hypertension, diabetus mellitus, and metabolic syndrome, assessed at middle age, and dementia. Studies assessing the link between hypercholesterolemia, atrial fibrillation, smoking, and dementia have given more conflicting results. Furthermore, some studies have highlighted the possible protective effect of antihypertensive therapy on cognition and some trials are evaluating the effects of statins and treatments for insulin resistance. Vascular risk factors and their treatments are a promising avenue of research for prevention of dementia, and further long-term, placebo-controlled, randomized studies, need to be performed.

Keywords: dementia, hypertension, diabetus mellitus, hypercholesterolemia, metabolic syndrome

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

The challenges of pain management in primary care: a pan-European survey

Johnson M, Collett B, Castro-Lopes JM

Journal of Pain Research 2013, 6:393-401

Published Date: 22 May 2013

Proposal for Alzheimer’s diagnosis using molecular buffer and bus network

Mitatha S, Moongfangklang N, Jalil MA, Suwanpayak N, Saktioto T, Ali J, Yupapin PP

International Journal of Nanomedicine 2011, 6:1209-1216

Published Date: 14 June 2011

Risk of “silent stroke” in patients older than 60 years: risk assessment and clinical perspectives

Jae-Sung Lim, Hyung-Min Kwon

Clinical Interventions in Aging 2010, 5:239-251

Published Date: 2 September 2010

Case of endogenous endophthalmitis caused by Streptococcus equisimilis

Shinsuke Suemori, Akira Sawada, Shinya Komori, et al

Clinical Ophthalmology 2010, 4:917-918

Published Date: 12 August 2010

Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension

Amber Lundy, Nahla Lutfi, Cherylyn Beckey

Vascular Health and Risk Management 2009, 5:429-440

Published Date: 8 May 2009

The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man

Alessandra Del Fiorentino, Silvana Cianchetti, Alessandro Celi, Giulia Dell’Omo, Roberto Pedrinelli

Vascular Health and Risk Management 2009, 5:233-242

Published Date: 8 February 2009

Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives

Francesco Chiarelli, Daniele Di Marzio

Vascular Health and Risk Management 2008, 4:297-304

Published Date: 5 May 2008

Automated detection of proliferative retinopathy in clinical practice

Audrey Karperien, Herbert F Jelinek, Jorge JG Leandro, João VB Soares, Roberto M Cesar Jr, Alan Luckie

Clinical Ophthalmology 2008, 2:109-122

Published Date: 17 March 2008

Gadofosveset-enhanced magnetic resonance angiography

Mathias Goyen

Vascular Health and Risk Management 2008, 4:1-9

Published Date: 5 March 2008